Last reviewed · How we verify
NCT05555433: Calprotectine
Calprotectine in Spondyloarthritis
trial testing NO INTERVENTION in Spondylarthritis in 190 participants. Currently enrolling.
15 August 2024
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nice |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 190 |
| Start date | 15 August 2022 |
| Primary completion | 15 August 2024 |
| Estimated completion | 15 August 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- NO INTERVENTION
Conditions studied
- Spondylarthritis — all drugs for Spondylarthritis →
Sponsor
Centre Hospitalier Universitaire de Nice
Who can join
18 and older, any sex, with Spondylarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To date, there are no biomarkers in spondyloarthritis that can differentiate between spondyloarthritis and fibromyalgia or other pathologies. Fecal calprotectin is a biomarker that is increasingly used in inflammatory diseases of the digestive tract. A growing interest in this biomarker is emerging in rheumatology, several publications have focused on its interest in rheumatoid arthritis, highlighting an association between serum calprotectin levels and disease activity. In spondyloarthritis, a few studies seem to show that it could be a marker of disease activity. Although a 2012 study found no difference in serum calprotectin levels between subjects with spondyloarthritis and controls. Still others have shown that it could be a predictive factor of radiological evolution in the same disease key. These data support, despite the questionable results of the Klingberg study, the value of this dosage in spondyloarthritis. The objective of this work is to show that this assay could be useful to differentiate spondyloarthritis from other pathologies with similar clinical presentation such as fibromyalgia. Difficulties classically encountered in common practice in rheumatology
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05555433
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NO INTERVENTION
Trials testing the same drug.
- NCT07221526 — SPO2 VALIDATION STUDY - PHILIPS FAST 2025 · completed
- NCT06405503 — Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease · not yet recruiting
- NCT06102629 — Ovary Syndrome for Efficient Diagnosis and Targeted Therapy · NA · not yet recruiting
- NCT05931133 — Urdu Translation and Validation of Michigan Hand Outcome Questionnaire · unknown
- NCT05815108 — Epstein Barr Virus Infection in Patients With Radiologically Isolated Syndrome · completed
Other recruiting trials for Spondylarthritis
Currently open trials in the same condition.
- NCT06320899 — Mid- or High-flex Rods Versus Low-flex Rods of SpineShape System IV for Treatment of Degenerative Lumbar Spine Diseases · NA · recruiting
- NCT06460805 — axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis · NA · recruiting
- NCT05926453 — Assessment of Cardiorespiratory Fitness in Spondylarthritis · active not recruiting
- NCT06720376 — Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis · recruiting
- NCT05592574 — IL17 Rate and Spondyloarthritis · recruiting
Other Centre Hospitalier Universitaire de Nice trials
Trials by the same sponsor.
- NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
- NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
- NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
- NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
- NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05555433 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
- Last refreshed: 17 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05555433.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing